Loading clinical trials...
Loading clinical trials...
A Randomized, Triple Blinded Cross-over Placebo Controlled Study of Effects of Inhaled Cannabidiol in Healthy Occasional Cannabis Users
Conditions
Interventions
Cannabis, placebo
Start Date
September 1, 2026
Primary Completion Date
October 1, 2027
Completion Date
December 1, 2027
Last Updated
December 22, 2025
NCT05602649
NCT04810858
NCT05855668
NCT06878859
NCT07196462
NCT07417059
Lead Sponsor
Centre hospitalier de l'Université de Montréal (CHUM)
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions